Vascular and cellular targeting for photodynamic therapy

Area of Science:

• Oncology
• Biomedical Engineering
• Photochemistry

Background:

• Photodynamic therapy (PDT) is an established medical treatment combining photosensitizers (PS) with light.
• Primary applications include age-related macular degeneration (AMD) and various cancers.
• PDT can damage tumor vasculature and parenchyma cells.

Purpose of the Study:

• To review current strategies for vascular and cellular targeting in PDT.
• To explore how photosensitizer properties and drug-light intervals influence targeting.
• To summarize advancements in active targeting of tumor markers.

Main Methods:

• Review of existing literature on PDT targeting mechanisms.
• Analysis of passive targeting via photosensitizer pharmacokinetics and molecular structure.
• Examination of active targeting strategies utilizing tumor cell and endothelial markers.

Main Results:

• Drug-light interval and photosensitizer properties dictate vascular versus cellular targeting.
• Shorter intervals favor vascular targeting; longer intervals favor cellular targeting.
• Extensive research into active targeting of various tumor surface, nuclear, and endothelial markers.

Conclusions:

• PDT targeting is tunable through passive and active mechanisms.
• Modifying photosensitizers and treatment parameters offers precise control over therapeutic effects.
• Continued research is advancing intracellular targeting and marker-specific delivery for enhanced PDT efficacy.